Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Cost-effectiveness of harm reduction in preventing hepatitis C among injection drug users.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cost-effectiveness of harm reduction in preventing hepatitis C among injection drug users.
Cost-effectiveness of harm reduction in preventing hepatitis C among injection drug users. Med Decis Making. 2001 Sep-Oct; 21(5):357-67.
View in:
PubMed
subject areas
Blood-Borne Pathogens
Cost-Benefit Analysis
Effect Modifier, Epidemiologic
Health Care Costs
Hepatitis C
HIV Infections
Humans
Models, Econometric
Needle Sharing
Needle-Exchange Programs
Prevalence
Risk-Taking
Substance Abuse, Intravenous
authors with profiles
Harold A. Pollack